Regular Article
Barrett's Esophagus and Associated Adenocarcinoma in a Mouse Surgical Model

https://doi.org/10.1006/jsre.1999.5774Get rights and content

Abstract

Background. The development of Barrett's esophagus (BE) and Barrett's associated adenocarcinoma (BAA) in the rat after experimental inducement of esophageal reflux of gastric, bile, and pancreatic juice has been reported by others. The purpose of this study was to determine whether similar results could be demonstrated in the mouse model.

Materials and methods. One hundred eight Swiss–Webster mice were used in this study and were divided into three groups: Group I, 37 mice with esophagojejunostomy; Group II, 39 mice with esophagojejunostomy and the carcinogen N-methyl-N-benzylnitrosamine (MBN); and Group III, 32 mice with MBN alone. The animals were sacrificed after 19 weeks. Macroscopic and histopathologic examinations were performed.

Results. One hundred mice survived and were available for pathologic study. Macroscopic evidence suggested esophagitis in 60.6% of mice in Group I, 62.8% of mice in Group II, and 9% of mice in Group III and suggested tumor in 3% of mice in Group I, 51.4% of mice in Group II, and 53.1% of mice in Group III. Histopathologic analysis disclosed BE in 42.4% of mice in Group I, 20% of mice in Group II, and 12.5% of mice in Group III. Cancer was present in 12.2% of mice in Group I, 54.3% of mice in Group II, and 46.9% of mice in Group III. Adenocarcinoma with or without squamous cell carcinoma was present in 6.1% of mice in Group I, 37.1% of mice in Group II, and 12.5% of mice in Group III.

Conclusions. Esophagojejunostomy plus MBN in the mouse results in BE, BAA, or both in 57.1% of animals, consistent with findings in the rat model after similar interventions.

References (17)

There are more references available in the full text version of this article.

Cited by (40)

  • Columnar Metaplasia in Three Types of Surgical Mouse Models of Esophageal Reflux

    2017, Cellular and Molecular Gastroenterology and Hepatology
    Citation Excerpt :

    The mortality rate of EGJ was 13.0% (6/46), EJ was 11.6% (5/43), and EJ/TG was 13.0% (6/46). All 3 groups of operations had similar mortality rates, also comparable with reported studies using rats or mice.6–8,16–23 All deaths in the EGJ group occurred in the first 30 days following the operation, in contrast with the other 2 groups, where they were more scattered along the follow-up period.

  • Preclinical models for the study of barrett’s carcinogenesis

    2018, Annals of the New York Academy of Sciences
  • Molecular biology of the Esophagus and stomach

    2018, DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology
View all citing articles on Scopus

This research was supported in part by the Allen Jarabek Esophageal Cancer Research Fund and the Thelma and Jerry Stergios Thoracic Surgery Education and Research Fund.

View full text